Back to Search
Start Over
Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
- Source :
-
Journal of the American College of Cardiology [J Am Coll Cardiol] 2006 Jan 03; Vol. 47 (1), pp. 22-6. Date of Electronic Publication: 2005 Dec 13. - Publication Year :
- 2006
-
Abstract
- Drug-eluting stents (DES) constitute a major breakthrough in restenosis prevention after initial percutaneous coronary intervention (PCI). Target lesion and vessel revascularization rates of <10% at six months follow-up represent a significant medical advance. Many cardiologists consider it reasonable to assume that PCI using DES ought to be considered equivalent, if not superior, to bypass surgery. The argument made is that in previous randomized clinical trials comparing PCI to coronary artery bypass grafting, restenosis was the determining factor favoring surgery, an event that clinical experience suggests is no longer as frequent. In the absence of a definitive clinical trial to support this view, how should the prudent, cutting edge cardiologist evaluate the data and manage their patients?
Details
- Language :
- English
- ISSN :
- 1558-3597
- Volume :
- 47
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of the American College of Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 16386659
- Full Text :
- https://doi.org/10.1016/j.jacc.2005.08.057